Centene Corp (CNC) Stock Price Today
Aura AI Summary
Key Stats
- $30.05BMarket Cap
- -Volume
- HealthSector
- $68.7252W High
- $25.2152W Low
- -Typical Hold Time
- $19.10BEnterprise Value
- -Div Yield
- -Trading Activity
Track Centene Corp (CNC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Centene Corp has traded between a low of $25.21 and a high of $68.72, highlighting its annual price range. Buy and sell Centene Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Most Recent News
SPY faces volatility as chip selloff pressures S&P 500, marking first July decline since 2014.
The SPDR S&P 500 ETF Trust (SPY) experienced increased volatility at the end of July 2026 due to a sharp selloff in semiconductor stocks, which heavily impacted the technology sector and the broader S&P 500 index. This selloff contributed to the S&P ...
Tesla predicted to lose its trillion-dollar market cap before 2027.
A prediction has been made that Tesla will lose its trillion-dollar market capitalization before the year 2027. This suggests a significant shift in investor confidence or market conditions affecting Tesla's valuation. The forecast highlights potenti...
Diebold Nixdorf CFO buys shares after strong Q2 with 1.4% revenue growth and 17% EPS rise
Diebold Nixdorf's CFO Timko Thomas S purchased 700 shares at $72.29 following the company's strong Q2 2026 results. The company reported a 1.4% revenue increase to $928 million and an 8% rise in adjusted EBITDA to $121 million. Adjusted EPS surged 17...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.